Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Isoquinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel benzophenone route for Solifenacin intermediate. Cost-effective, eco-friendly, high purity manufacturing process detailed in patent CN111925266A.
Patent CN103102304B reveals efficient trifluorosulfonate catalysis for high-purity pharmaceutical intermediates with reduced steps and scalable yield for global supply.
Patent CN114516835B reveals mild oxidation cascade for high purity intermediates. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing partners globally.
Patent CN105985290B reveals oxidant-free visible light photocatalysis for isoquinoline derivatives. This method ensures high purity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN105237532A reveals enzymatic route for L-praziquantel. Offers high optical purity and greener manufacturing for reliable pharmaceutical intermediate supply chains.
Novel visible-light method for isoquinoline derivatives offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Patent CN108484499A reveals a green rhodium-catalyzed route for isoquinoline derivatives, offering supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN108484499A reveals green rhodium catalyzed synthesis. Enables cost reduction in pharmaceutical intermediate manufacturing with high purity and supply reliability.
Patent CN107384885B reveals enzymatic synthesis of chiral amines. Achieve cost reduction in API manufacturing with high conversion and optical purity.
Patent CN110835639A reveals a dual-enzyme DKR process for high-purity (S)-tetrahydroisoquinoline derivatives, offering superior ee values and scalable manufacturing for pharmaceutical intermediates.
Patent CN110317849B reveals a high-yield enzymatic method for producing chiral tetrahydroisoquinoline intermediates, offering significant cost and purity advantages for pharmaceutical manufacturing.
Patent CN110835639B reveals a high-efficiency enzymatic route for producing chiral tetrahydroisoquinoline intermediates with superior stereoselectivity and scalable manufacturing potential.
Patent CN110790752B reveals a metal-free acid-catalyzed route for isoquinoline substituted flavones, offering significant cost reduction in API manufacturing and streamlined supply chains.
Novel three-step route for high-purity isoquinoline derivatives offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel palladium-catalyzed route ensures high purity pharmaceutical intermediates with scalable cost reduction and supply chain reliability for global buyers.
Patent CN117024342A reveals a novel one-pot synthesis for phenanthridine OLED materials, offering high purity and reduced manufacturing costs for electronic chemical supply chains.
Novel zinc-mediated reduction route for Roxadustat intermediates. High purity, scalable, and cost-effective manufacturing solution for pharmaceutical supply chains.
Enzymatic resolution patent CN112442523B enables high-purity chiral intermediate production with reduced costs and scalable supply chain reliability for global pharma.
Patent CN110903242A reveals a safer, high-yield route for Roxadustat intermediates. Discover cost-effective manufacturing solutions for HIF-PHI inhibitors.
Patent CN1139576C details a novel iridium-catalyzed asymmetric hydrogenation process for producing high-purity dextromethorphan intermediates with enhanced supply chain reliability.